Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma

NCT01703507 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Melanoma
Stage IV Melanoma
Tumors Metastatic to Brain

Interventions

DRUG: Ipilimumab
RADIATION: Whole-Brain Radiation Therapy (WBRT)
RADIATION: Stereotactic Radiosurgery (SRS)

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]